Coliforms

• Rapid and Accurate Determination of Lipopolysaccharide O - Antigen Types in Klebsiella pneumoniae with a Novel PCR - Based O - Genotyping Method
• Cyclic AMP - CRP Modulates the Cell Morphology of Klebsiella pneumoniae in High - Glucose Environment
• The diversity of Klebsiella pneumoniae surface polysaccharides
• Interaction of Klebsiella pneumoniae with tissue macrophages in a mouse infection model and ex - vivo pig organ perfusions: an exploratory investigation
• Phototypic and Genotypic Characterization of Klebsiella pneumoniae Isolated From Retail Foods in China
• Epidemiology and Outcome of Klebsiella Species Bloodstream Infection: A Population - Based Study
• Coliforms include Klebsiella, Enterobacter, and Citrobacter, all of which are lactose fermenters.
• Citrobacter produces CO2 gas, Enterobacter produces H2S gas, and Klebsiella produces no gas.
• Citrobacter, Enterobacter, and Klebsiella can be differentiated through their habitats, host ranges, virulence factors, types of diseases they cause, isolation and identification methods, and treatment and control methods.
• Klebsiella has three species that are super important: K. pneumoniae, K. oxytoca, and K. aerogenes.
• Carbapenem - resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers
• Prevalence, risk factors, outcomes, and molecular epidemiology of mcr - 1 - positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical study
• A Systematic Review and Meta - analysis of Antibiotic Treatment Duration for Bacteremia Due to Enterobacteriaceae
• Macrocolony of NDM - 1 Producing Enterobacter hormaechei subsp. oharae Generates Subpopulations with Different Features Regarding the Response of Antimicrobial Agents and Biofilm Formation
• Enterobacter bugandensis: a novel enterobacterial species associated with severe clinical infection
• Risk factors for relapse or persistence of bacteraemia caused by Enterobacter spp.: a case – control study
• Bloodstream Infections Caused by Enterobacter Species: Predictors of 30 - Day Mortality Rate and Impact of Broad - Spectrum Cephalosporin Resistance on Outcome
• Precise Species Identification for Enterobacter: a Genome Sequence - Based Study with Reporting of Two Novel Species, Enterobacter quasiroggenkampii sp. nov. and Enterobacter quasimori sp. nov.
• Enterobacter cloacae colonisation and infection in a neonatal intensive care unit: retrospective investigation of preventive measures implemented after a multiclonal outbreak
• Klebsiella is unique because it is a Gram-negative bacteria with a somatic (O) antigen, is a lactose fermenter, has a highly mucoid colony due to a very thick capsule, is non-motile, does not produce H2S gas, and is urease positive.
• Klebsiella has 8 to 11 different O serotypes (O antigens) and 77 to 80 different K antigens (K serotypes).
• ESBL genes confer resistance to most β-lactam antibiotics such as cephalosporins and monobactams.
• Plasmids for multi-drug resistance are associated with Enterobacter cloacae, a member of the ESKAPE group, which contains the major resistant bacterial pathogens.
• bla KPC genes confer resistance to the last-resort carbapenems meropenem, imipenem, and ertapenem.
• The emergence of multidrug resistance (MDR) is a significant concern in healthcare settings.
• Isolation, identification, and diagnosis methods of Enterobacter include biochemical tests, serology, and molecular techniques.
• Enterobacter cloacae is associated with diseases in immunocompromised patients, urinary tract infection, intra-abdominal infection, pneumonia, bacteremia/septicemia, and wounds.
• The coliforms and Proteus are known to cause diseases at sites of colonization and extraintestinal disease production.
• Klebsiella spp. can be identified as nosocomial pathogens through their epidemiology, taxonomy, typing methods, and pathogenicity factors.
• Klebsiella spp. can cause various diseases such as urinary tract infections, pneumonia, and sepsis.
• Klebsiella spp. can be isolated and identified through various methods such as culture, serology, and polymerase chain reaction (PCR).
• Treatment and control methods for Klebsiella spp. include antibiotics, disinfectants, and hygiene measures.
• Comparative Genomic Analysis of Citrobacter and Key Genes Essential for the Pathogenicity of Citrobacter koseri is a study by Frontiers.
• Antimicrobial Resistance and Cytotoxicity of Citrobacter spp. in Maanshan, Anhui Province, China is a study by Frontiers.
• Citrobacter freundii exhibits fitness during bloodstream infection.
• Citrobacter: An emerging health care associated urinary pathogen is an article by PMC (nih.gov).
• A mouse model of Citrobacter rodentium oral infection and evaluation of innate and adaptive immune responses is an article by ScienceDirect.
• Properdin Provides Protection from Citrobacter rodentium-Induced Intestinal Inflammation in a C5a/IL-6-Dependent Manner is an article by The Journal of Immunology.
• IL-23-mediated mononuclear phagocyte crosstalk protects mice from Citrobacter rodentium-induced colon immunopathology is an article by Nature Communications.
• Klebsiella spp. are a part of the ESKAPE pathogens, which includes Enterobacter, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa.